Gene therapy for autoimmune diseases:: Quo Vadis?

被引：38
作者：
Chernajovsky, Y
Gould, DJ
Podhajcer, OL
机构：
[1] Univ London, Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, Bone & Joint Res Unit, London EC1M 6BQ, England
[2] Univ Buenos Aires, Fac Exact & Nat Sci, CONICET, Inst Leloir, Buenos Aires, DF, Argentina
来源：
NATURE REVIEWS IMMUNOLOGY | 2004年 / 4卷 / 10期
基金：
英国惠康基金;
关键词：
D O I：
10.1038/nri1459
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Biological therapies using antibodies and cytokines are becoming widespread for the treatment of chronic inflammatory autoimmune diseases. However, these treatments have several limitations - such as expense, the need for repeated injections and unwanted side-effects - that can be overcome by genetic delivery. This review summarizes the ingenuity, sophistication and variety of gene-therapy approaches that have been taken in the design of therapeutic molecules and vectors, the engineering of cells and the regulation of gene expression for the targeting of disease outcome. We focus our attention on multiple sclerosis, type 1 diabetes and rheumatoid arthritis.
引用
收藏
页码：800 / 811
页数：12
相关论文
共 147 条
  • [1] Targeting cytokines to inflammation sites
    Adams, G
    Vessillier, S
    Dreja, H
    Chernajovsky, Y
    [J]. NATURE BIOTECHNOLOGY, 2003, 21 (11) : 1314 - 1320
  • [2] Adenoviral delivery of soluble VEGF receptor 1 (sFlt-1) abrogates disease activity in murine collagen-induced arthritis
    Afuwape, AO
    Feldmann, M
    Paleolog, EM
    [J]. GENE THERAPY, 2003, 10 (23) : 1950 - 1960
  • [3] Ex vivo and systemic transfer of adenovirus-mediated CTLA4Ig gene combined with a short course of FK506 therapy prolongs islet graft survival
    Akamaru, Y
    Ito, T
    Uchikoshi, F
    Maeda, A
    Tori, M
    Kiyomoto, T
    Komoda, H
    Miao, G
    Matsuda, H
    [J]. TRANSPLANT IMMUNOLOGY, 2003, 11 (01) : 91 - 100
  • [4] Engineering mouse T lymphocytes specific to type II collagen by transduction with a chimeric receptor consisting of a single chain Fv and TCR zeta
    Annenkov, A
    Chernajovsky, Y
    [J]. GENE THERAPY, 2000, 7 (08) : 714 - 722
  • [5] Annenkov AE, 1998, J IMMUNOL, V161, P6604
  • [6] Clustering of immunoreceptor tyrosine-based activation motif-containing signalling subunits in CD4+ T cells is an optimal signal for IFN-γ production, but not for the production of IL-4
    Annenkov, AE
    Daly, GM
    Brocker, T
    Chernajovsky, Y
    [J]. INTERNATIONAL IMMUNOLOGY, 2003, 15 (05) : 665 - 677
  • [7] Tetracycline-inducible interleukin-10 gene transfer mediated by an adeno-associated virus:: Application to experimental arthritis
    Apparailly, F
    Millet, V
    Noël, D
    Jacquet, C
    Sany, J
    Jorgensen, C
    [J]. HUMAN GENE THERAPY, 2002, 13 (10) : 1179 - 1188
  • [8] Apparailly F, 2001, ARTHRITIS RHEUM-US, V44, P1444, DOI 10.1002/1529-0131(200106)44:6<1444::AID-ART240>3.0.CO
  • [9] 2-Q
  • [10] IL-1 produced and released endogenously within human islets inhibits β cell function
    Arnush, M
    Heitmeier, MR
    Scarim, AL
    Marino, MH
    Manning, PT
    Corbett, JA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (03) : 516 - 526
12345678910